Cargando…
Cancer bio-immunotherapy XVII annual NIBIT (Italian Network for Tumor Biotherapy) meeting, October 11–13 2019, Verona, Italy
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577637/ https://www.ncbi.nlm.nih.gov/pubmed/34755203 http://dx.doi.org/10.1007/s00262-021-03104-1 |
| _version_ | 1784596100465819648 |
|---|---|
| author | Bellone, Matteo Bregni, Marco Bronte, Vincenzo Ugel, Stefano Ferrucci, Pier Francesco Di Nicola, Massimo Nisticò, Paola Zuccolotto, Gaia Rosato, Antonio Russo, Vincenzo Sica, Antonio Colombo, Mario P. |
| author_facet | Bellone, Matteo Bregni, Marco Bronte, Vincenzo Ugel, Stefano Ferrucci, Pier Francesco Di Nicola, Massimo Nisticò, Paola Zuccolotto, Gaia Rosato, Antonio Russo, Vincenzo Sica, Antonio Colombo, Mario P. |
| author_sort | Bellone, Matteo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8577637 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85776372021-11-10 Cancer bio-immunotherapy XVII annual NIBIT (Italian Network for Tumor Biotherapy) meeting, October 11–13 2019, Verona, Italy Bellone, Matteo Bregni, Marco Bronte, Vincenzo Ugel, Stefano Ferrucci, Pier Francesco Di Nicola, Massimo Nisticò, Paola Zuccolotto, Gaia Rosato, Antonio Russo, Vincenzo Sica, Antonio Colombo, Mario P. Cancer Immunol Immunother Letter to the Editors Springer Berlin Heidelberg 2021-11-09 2022 /pmc/articles/PMC8577637/ /pubmed/34755203 http://dx.doi.org/10.1007/s00262-021-03104-1 Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Letter to the Editors Bellone, Matteo Bregni, Marco Bronte, Vincenzo Ugel, Stefano Ferrucci, Pier Francesco Di Nicola, Massimo Nisticò, Paola Zuccolotto, Gaia Rosato, Antonio Russo, Vincenzo Sica, Antonio Colombo, Mario P. Cancer bio-immunotherapy XVII annual NIBIT (Italian Network for Tumor Biotherapy) meeting, October 11–13 2019, Verona, Italy |
| title | Cancer bio-immunotherapy XVII annual NIBIT (Italian Network for Tumor Biotherapy) meeting, October 11–13 2019, Verona, Italy |
| title_full | Cancer bio-immunotherapy XVII annual NIBIT (Italian Network for Tumor Biotherapy) meeting, October 11–13 2019, Verona, Italy |
| title_fullStr | Cancer bio-immunotherapy XVII annual NIBIT (Italian Network for Tumor Biotherapy) meeting, October 11–13 2019, Verona, Italy |
| title_full_unstemmed | Cancer bio-immunotherapy XVII annual NIBIT (Italian Network for Tumor Biotherapy) meeting, October 11–13 2019, Verona, Italy |
| title_short | Cancer bio-immunotherapy XVII annual NIBIT (Italian Network for Tumor Biotherapy) meeting, October 11–13 2019, Verona, Italy |
| title_sort | cancer bio-immunotherapy xvii annual nibit (italian network for tumor biotherapy) meeting, october 11–13 2019, verona, italy |
| topic | Letter to the Editors |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577637/ https://www.ncbi.nlm.nih.gov/pubmed/34755203 http://dx.doi.org/10.1007/s00262-021-03104-1 |
| work_keys_str_mv | AT bellonematteo cancerbioimmunotherapyxviiannualnibititaliannetworkfortumorbiotherapymeetingoctober11132019veronaitaly AT bregnimarco cancerbioimmunotherapyxviiannualnibititaliannetworkfortumorbiotherapymeetingoctober11132019veronaitaly AT brontevincenzo cancerbioimmunotherapyxviiannualnibititaliannetworkfortumorbiotherapymeetingoctober11132019veronaitaly AT ugelstefano cancerbioimmunotherapyxviiannualnibititaliannetworkfortumorbiotherapymeetingoctober11132019veronaitaly AT ferruccipierfrancesco cancerbioimmunotherapyxviiannualnibititaliannetworkfortumorbiotherapymeetingoctober11132019veronaitaly AT dinicolamassimo cancerbioimmunotherapyxviiannualnibititaliannetworkfortumorbiotherapymeetingoctober11132019veronaitaly AT nisticopaola cancerbioimmunotherapyxviiannualnibititaliannetworkfortumorbiotherapymeetingoctober11132019veronaitaly AT zuccolottogaia cancerbioimmunotherapyxviiannualnibititaliannetworkfortumorbiotherapymeetingoctober11132019veronaitaly AT rosatoantonio cancerbioimmunotherapyxviiannualnibititaliannetworkfortumorbiotherapymeetingoctober11132019veronaitaly AT russovincenzo cancerbioimmunotherapyxviiannualnibititaliannetworkfortumorbiotherapymeetingoctober11132019veronaitaly AT sicaantonio cancerbioimmunotherapyxviiannualnibititaliannetworkfortumorbiotherapymeetingoctober11132019veronaitaly AT colombomariop cancerbioimmunotherapyxviiannualnibititaliannetworkfortumorbiotherapymeetingoctober11132019veronaitaly |